Andrey V. Polosin
Andrey V. Polosin has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Pavel V. Postnikov
National Anti‐Doping Laboratory (Institute) Lomonosov Moscow State University (NADL MSU) Moscow Russia
5 shared publications - Yuliya A. Efimova
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)
4 shared publications - Elena S. Mochalova
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)
2 shared publications - N. B. Savelieva
National Anti-Doping Laboratory (Institute), M.V. Lomonosov Moscow State University (NADL MSU)
2 shared publications - S. A. Kurbatkin
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)
2 shared publications - Alexander D. Askretkov
PHARMAPARK
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 21 (4) , 448-458
Quantitative evaluation of meldonium by HPLC–MS/MS in meat of animals injected with Emidonol® and urine samples of volunteers after consumption of this meat in food
Objectives. In recent years, the issue of food contamination with substances on the World Anti-Doping Agency (WADA) Prohibited List has become particularly pressing. Meldonium, prohibited in sport under Article S4.4, may be unintentionally consumed by athletes via the use of the veterinary drug Emidonol ® , approved by the Federal Service for Veterinary and Phytosanitary Surveillance ( Rosselkhoznadzor ), in farm animals. Two studies have already been published on the determination of meldonium in meat samples contaminated with the veterinary drug. However, its concentrations in urine samples obtained from volunteers following heat treatment and consumption of such meat have not yet been determined, nor has the duration of its urinary excretion been studied, both factors being important for rigorous anti-doping control. The present study therefore set out to quantitatively evaluate meldonium in samples of raw meat obtained from calves slaughtered on the 15th ( n = 3) and 30th ( n = 3) days following a course of Emidonol® injections, as well as to study the kinetics of its excretion in urine following the single consumption of 350 g of meat contaminated with it. Methods. Raw meat samples were prepared using methanol–water extraction followed by acetonitrile protein precipitation, while urine samples were prepared using the dilute-and-shoot approach. High-performance liquid chromatography tandem mass spectrometry (HPLC–MS/MS) under electrospray ionization conditions with positive ion detection (ESI+) was used for analysis. Meldonium was identified in selective reaction monitoring (SRM) mode using following SRM transitions and collision energies: 147 > 147 (10), 147 > 58 (17), 147 > 59 (17) for meldonium and 150 > 61 (30) for meldonium-d 3 (Internal Standard). Results. Meldonium concentrations in raw meat samples from calves slaughtered 15 days after completion of the veterinary drug course ranged from 1428 ± 43 to 2627 ± 14 ng per 0.5 g; after 30 days, the corresponding concentrations varied from 922 ± 13 to 1558 ± 28 ng per 0.5 g. Following heat treatment and consumption of the meat samples, maximum concentrations of meldonium in urine reached after 2–5 h following consumption varied depending on the cooking method from 219 ± 2 to 386 ± 1 ng/mL, which significantly exceeds the WADA Minimum Required Performance Level (MRPL). Meldonium was still present in detectable amounts in the urine of volunteers 24–28 h after consumption of the Emidonol® - contaminated meat. Conclusions. The potential for unintended meldonium use in athletes through the consumption of meat from farm animals contaminated with Emidonol® has been demonstrated. The tested levels could lead to a positive doping test and appropriate sanctions against the athlete.
- 10 September 2026
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 21 (4) , 448-458
Open AccessQuantitative evaluation of meldonium by HPLC–MS/MS in meat of animals injected with Emidonol® and urine samples of volunteers after consumption of this meat in food
Objectives. In recent years, the issue of food contamination with substances on the World Anti-Doping Agency (WADA) Prohibited List has become particularly pressing. Meldonium, prohibited in sport under Article S4.4, may be unintentionally consumed by athletes via the use of the veterinary drug Emidonol ® , approved by the Federal Service for Veterinary and Phytosanitary Surveillance ( Rosselkhoznadzor ), in farm animals. Two studies have already been published on the determination of meldonium in meat samples contaminated with the veterinary drug. However, its concentrations in urine samples obtained from volunteers following heat treatment and consumption of such meat have not yet been determined, nor has the duration of its urinary excretion been studied, both factors being important for rigorous anti-doping control. The present study therefore set out to quantitatively evaluate meldonium in samples of raw meat obtained from calves slaughtered on the 15th ( n = 3) and 30th ( n = 3) days following a course of Emidonol® injections, as well as to study the kinetics of its excretion in urine following the single consumption of 350 g of meat contaminated with it. Methods. Raw meat samples were prepared using methanol–water extraction followed by acetonitrile protein precipitation, while urine samples were prepared using the dilute-and-shoot approach. High-performance liquid chromatography tandem mass spectrometry (HPLC–MS/MS) under electrospray ionization conditions with positive ion detection (ESI+) was used for analysis. Meldonium was identified in selective reaction monitoring (SRM) mode using following SRM transitions and collision energies: 147 > 147 (10), 147 > 58 (17), 147 > 59 (17) for meldonium and 150 > 61 (30) for meldonium-d 3 (Internal Standard). Results. Meldonium concentrations in raw meat samples from calves slaughtered 15 days after completion of the veterinary drug course ranged from 1428 ± 43 to 2627 ± 14 ng per 0.5 g; after 30 days, the corresponding concentrations varied from 922 ± 13 to 1558 ± 28 ng per 0.5 g. Following heat treatment and consumption of the meat samples, maximum concentrations of meldonium in urine reached after 2–5 h following consumption varied depending on the cooking method from 219 ± 2 to 386 ± 1 ng/mL, which significantly exceeds the WADA Minimum Required Performance Level (MRPL). Meldonium was still present in detectable amounts in the urine of volunteers 24–28 h after consumption of the Emidonol® - contaminated meat. Conclusions. The potential for unintended meldonium use in athletes through the consumption of meat from farm animals contaminated with Emidonol® has been demonstrated. The tested levels could lead to a positive doping test and appropriate sanctions against the athlete.
- Open Access
- 2 September 2025
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 20 (4) , 382-398
Semiquantitative determination of meldonium and emoxypine in human urine by HPLC–MS/MS after receiving a single therapeutic dose of Brainmax® and milk from cows receiving a preventive course of Emidonol®
Objectives. Emidonol® is a veterinary drug used to treat pathological conditions associated with hypoxia in cattle. In addition tomeldonium, which is included in the Prohibited List of the World Anti-Doping Agency, the biotransformation product of Emidonol® in animals is the antioxidant and antihypoxant emoxypine, which can act as a marker of contamination of food products with the above-mentioned widely known metabolic modulator. The study set out to semiquantitatively determine emoxypine and meldonium levels, as well as to compare the excretion profiles of these substances by high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) in urine samples of volunteers after receiving a single oral administration of a therapeutic dose of Brainmax® and after consuming a large amount of milk from cows that had received a prophylactic course of Emidonol®.Methods. Sample preparation of urine samples for the determination of meldonium was carried out using the “dilute and shoot” approach. Enzymatic hydrolysis with β-glucuronidase followed by purification by solid-phase extraction was used to determine emoxypine. Identification of meldonium and emoxypine was carried out by HPLC–MS/MS under conditions of electrospray ionization with registration of positively charged ions in the selective reaction monitoring (SRM) mode for the following transitions and collision energies: for meldonium, 147.1 > 147.1 (15), 147.1 > 132.1 (17), 147.1 > 58.1 (17), 147.1 > 59.1 (17), 147.1 > 42.1 (60); for emoxypine, 138.1 > 138.1 (7), 138.1 > 123.1 (15), 138.1 > 110.1 (20), 138.1 > 95.1 (20).Results. The possibility of simultaneous identifying meldonium and emoxypine obtained after enzymatic hydrolysis with β-glucuronidase in urine samples of volunteers after oral intake of single dose of Brainmax® and consuming a large amount of Emidonol®-contaminated milk using the HPLC–MS/MS method with different numbers and variants of SRM transitions was demonstrated. Differences in the excretion profiles of these substances were found after ingestion of large amounts of contaminated milk and a single oral dose of Brainmax® 15–18 h later and further. After taking contaminated milk 12 h or more later, emoxypine is detected in concentrations 5 or more times higher than meldonium concentrations and is excreted for a longer period of time. Conversely, after taking a single dose of Brainmax®, which contains both substances, the content of meldonium in urine samples of volunteers 15–18 h after taking it is several times higher in relation to emoxypine. The constant ratio of estimated concentrations of meldonium and emoxypine in Emidonol® was found to be approximately 1 : 2.Conclusions. Identification of meldonium in the presence of emoxypine in urine under certain conditions can be used to distinguish contamination of food products with a prohibited metabolic modulator from intentional ingestion of real doping.
- 2 September 2025
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 20 (4) , 382-398
Open AccessSemiquantitative determination of meldonium and emoxypine in human urine by HPLC–MS/MS after receiving a single therapeutic dose of Brainmax® and milk from cows receiving a preventive course of Emidonol®
Objectives. Emidonol® is a veterinary drug used to treat pathological conditions associated with hypoxia in cattle. In addition tomeldonium, which is included in the Prohibited List of the World Anti-Doping Agency, the biotransformation product of Emidonol® in animals is the antioxidant and antihypoxant emoxypine, which can act as a marker of contamination of food products with the above-mentioned widely known metabolic modulator. The study set out to semiquantitatively determine emoxypine and meldonium levels, as well as to compare the excretion profiles of these substances by high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) in urine samples of volunteers after receiving a single oral administration of a therapeutic dose of Brainmax® and after consuming a large amount of milk from cows that had received a prophylactic course of Emidonol®.Methods. Sample preparation of urine samples for the determination of meldonium was carried out using the “dilute and shoot” approach. Enzymatic hydrolysis with β-glucuronidase followed by purification by solid-phase extraction was used to determine emoxypine. Identification of meldonium and emoxypine was carried out by HPLC–MS/MS under conditions of electrospray ionization with registration of positively charged ions in the selective reaction monitoring (SRM) mode for the following transitions and collision energies: for meldonium, 147.1 > 147.1 (15), 147.1 > 132.1 (17), 147.1 > 58.1 (17), 147.1 > 59.1 (17), 147.1 > 42.1 (60); for emoxypine, 138.1 > 138.1 (7), 138.1 > 123.1 (15), 138.1 > 110.1 (20), 138.1 > 95.1 (20).Results. The possibility of simultaneous identifying meldonium and emoxypine obtained after enzymatic hydrolysis with β-glucuronidase in urine samples of volunteers after oral intake of single dose of Brainmax® and consuming a large amount of Emidonol®-contaminated milk using the HPLC–MS/MS method with different numbers and variants of SRM transitions was demonstrated. Differences in the excretion profiles of these substances were found after ingestion of large amounts of contaminated milk and a single oral dose of Brainmax® 15–18 h later and further. After taking contaminated milk 12 h or more later, emoxypine is detected in concentrations 5 or more times higher than meldonium concentrations and is excreted for a longer period of time. Conversely, after taking a single dose of Brainmax®, which contains both substances, the content of meldonium in urine samples of volunteers 15–18 h after taking it is several times higher in relation to emoxypine. The constant ratio of estimated concentrations of meldonium and emoxypine in Emidonol® was found to be approximately 1 : 2.Conclusions. Identification of meldonium in the presence of emoxypine in urine under certain conditions can be used to distinguish contamination of food products with a prohibited metabolic modulator from intentional ingestion of real doping.
- Open Access
- 3 November 2024
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 19 (5) , 393-407
Identification of hypoxene metabolites in urine samples using gas chromatography–tandem mass spectrometry for anti-doping control
Objectives. Hypoxen is a drug which possesses antioxidant and antihypoxic effects. It achieves this by increasing the utilization of oxygen by mitochondria, intensifying oxidative phosphorylation, and as a result, improving tissue respiration. Athletes take it during prolonged exercise, in order to increase efficiency and reduce physical overwork. Since 2023, the World Anti-Doping Agency has included the drug in the monitoring program, in the belief that it can be used to gain a competitive advantage. It is thus a candidate for inclusion in the Prohibited List as a potential regulator of the human metabolism. Currently, there are no studies or scientific publications focusing on the identification of hypoxene in biofluids for the purpose of anti-doping control. The aim of this study is to determine the possible metabolites of the drug and their chromato-mass spectrometric characteristics in urine samples using gas chromatography–tandem mass spectrometry (GC–MS/MS) for doping control screening purposes.Methods. Sample preparation of urine samples was carried out using enzymatic hydrolysis, liquid–liquid extraction and derivatization. The GC–MS/MS method was used for analysis. Screening of hypoxene metabolites was carried out in the mode of total ion current after fragmentation of selected parent ions.Results. Three specific metabolites of hypoxene (m/z 342, 300, and 346, including trimethylsilyl derivatives) were identified in urine samples of volunteers (n = 3). They can act as markers for taking the target antihypoxant, and their possible structural formulas are given. The excretion curves of two metabolites with an m/z of 300 and 346 respectively in urine were studied. The maximum concentration is reached after 8–14 and 1.5–6 h, respectively. It was established, that these metabolites are reliably identified in urine 90 h or more after a single dose of the drug.Conclusions. Possible structures of hypoxene metabolites in urine samples from volunteers were determined for the first time and their chromato-mass spectrometric characteristics were established. The approach developed in this study can be used for screening analysis of hypoxene for the purpose of anti-doping control.
- 3 November 2024
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 19 (5) , 393-407
Open AccessIdentification of hypoxene metabolites in urine samples using gas chromatography–tandem mass spectrometry for anti-doping control
Objectives. Hypoxen is a drug which possesses antioxidant and antihypoxic effects. It achieves this by increasing the utilization of oxygen by mitochondria, intensifying oxidative phosphorylation, and as a result, improving tissue respiration. Athletes take it during prolonged exercise, in order to increase efficiency and reduce physical overwork. Since 2023, the World Anti-Doping Agency has included the drug in the monitoring program, in the belief that it can be used to gain a competitive advantage. It is thus a candidate for inclusion in the Prohibited List as a potential regulator of the human metabolism. Currently, there are no studies or scientific publications focusing on the identification of hypoxene in biofluids for the purpose of anti-doping control. The aim of this study is to determine the possible metabolites of the drug and their chromato-mass spectrometric characteristics in urine samples using gas chromatography–tandem mass spectrometry (GC–MS/MS) for doping control screening purposes.Methods. Sample preparation of urine samples was carried out using enzymatic hydrolysis, liquid–liquid extraction and derivatization. The GC–MS/MS method was used for analysis. Screening of hypoxene metabolites was carried out in the mode of total ion current after fragmentation of selected parent ions.Results. Three specific metabolites of hypoxene (m/z 342, 300, and 346, including trimethylsilyl derivatives) were identified in urine samples of volunteers (n = 3). They can act as markers for taking the target antihypoxant, and their possible structural formulas are given. The excretion curves of two metabolites with an m/z of 300 and 346 respectively in urine were studied. The maximum concentration is reached after 8–14 and 1.5–6 h, respectively. It was established, that these metabolites are reliably identified in urine 90 h or more after a single dose of the drug.Conclusions. Possible structures of hypoxene metabolites in urine samples from volunteers were determined for the first time and their chromato-mass spectrometric characteristics were established. The approach developed in this study can be used for screening analysis of hypoxene for the purpose of anti-doping control.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 93 (5) , 94-103
Identification of meldonium in the urine of volunteers using high-performance liquid chromatography-tandem mass spectrometry after consumption of milk of cows treated with a preventive course of the veterinary drug Emidonol®
Выявление мельдония в моче добровольцев методом высокоэффективной жидкостной хроматографии в сочетании с тандемной масс-спектрометрией после
- 1 January 2024
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 93 (5) , 94-103
Open AccessIdentification of meldonium in the urine of volunteers using high-performance liquid chromatography-tandem mass spectrometry after consumption of milk of cows treated with a preventive course of the veterinary drug Emidonol®
Выявление мельдония в моче добровольцев методом высокоэффективной жидкостной хроматографии в сочетании с тандемной масс-спектрометрией после
- Open Access
- 31 July 2022
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 17 (3) , 253-267
Validation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS
Objectives. To validate a new method for the quantitative determination of 31 potent and narcotic substances and their metabolites in urine that meets the requirements of ISO/IEC 17025 using a fast and highly sensitive method of chromato-mass spectrometry with a view to introducing such a method into the routine practice of the National Anti-Doping Laboratory of the Lomonosov Moscow State University (NADL MSU).Methods. Urine samples soldered with standard solutions were analyzed using ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC–MS/MS).Results. Diagnostic precursor/ion-product pairs and collision energies were established to allow unambiguous identification of the analyzed substances. During sample preparation, hydrolysis conditions were optimized. Selectivity, linearity, limits of qualitative determination, limit of quantitative determination (established under the contract with the customer firm), matrix effect, and measurement uncertainty were defined. Systematized data grouped by classes of analytes are given in the final table.Conclusions. The important advantages of the presented technique are the absence of complex and lengthy sample preparation, as well as the short time of the analysis method (about 10 min), which can significantly reduce duration along with labor and analysis costs. The addition of new analytes will ensure the versatility of the technique, as well as expanding its scope.
- 31 July 2022
- Published by RTU MIREA in Fine Chemical Technologies
- Vol. 17 (3) , 253-267
Open AccessValidation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS
Objectives. To validate a new method for the quantitative determination of 31 potent and narcotic substances and their metabolites in urine that meets the requirements of ISO/IEC 17025 using a fast and highly sensitive method of chromato-mass spectrometry with a view to introducing such a method into the routine practice of the National Anti-Doping Laboratory of the Lomonosov Moscow State University (NADL MSU).Methods. Urine samples soldered with standard solutions were analyzed using ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC–MS/MS).Results. Diagnostic precursor/ion-product pairs and collision energies were established to allow unambiguous identification of the analyzed substances. During sample preparation, hydrolysis conditions were optimized. Selectivity, linearity, limits of qualitative determination, limit of quantitative determination (established under the contract with the customer firm), matrix effect, and measurement uncertainty were defined. Systematized data grouped by classes of analytes are given in the final table.Conclusions. The important advantages of the presented technique are the absence of complex and lengthy sample preparation, as well as the short time of the analysis method (about 10 min), which can significantly reduce duration along with labor and analysis costs. The addition of new analytes will ensure the versatility of the technique, as well as expanding its scope.